Rowe, IA, Villanueva, C, Shearer, JE, Torres, F, Albillos, A, Genesca, J, Garcia-Pagan, JC, Tripathi, D, Hayes, PC, Bosch, J, Abraldes, JG. Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial. HEPATOLOGY. 2023; 78(2)DOI:10.1097/HEP.0000000000000342. PMID:36897269. IF:13.000(Q1/1D).

Villanueva, C, Torres, F, Tripathi, D, Bosch, J, Carvedilol-IPD-MA-Grp. Reply to: "Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices". JOURNAL OF HEPATOLOGY. 2023; 79(1)DOI:10.1016/j.jhep.2023.02.025. PMID:36848975. IF:26.800(Q1/1D).

Martinez-Lopez, S, Angel-Gomis, E, Sanchez-Ardid, E, Pastor-Campos, A, Pico, J, Gomez-Hurtado, I. The 3Rs in Experimental Liver Disease. Animals. 2023; 13(14)DOI:10.3390/ani13142357. PMID:37508134. IF:2.700(Q1/1D).

Nicoara-Farcau, O, Lozano, JJ, Alonso, C, Sidorova, J, Villanueva, C, Albillos, A, Genesca, J, Llop, E, Calleja, JL, Aracil, C, Banares, R, Morillas, R, Poca, M, Penas, B, Augustin, S, Tantau, M, Thompson, M, Perez-Campuzano, V, Baiges, A, Turon, F, Hernandez-Gea, V, Abraldes, JG, Tapias, EA, Torres, F, Bosch, J, Garcia-Pagan, JC. Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis. HEPATOLOGY. 2023; 77(6)DOI:10.1097/HEP.0000000000000316. PMID:36811400. IF:13.000(Q1/1D).